摘要
目的探究对小儿哮喘急性发作患儿实施普米克令舒+硫酸沙丁胺醇治疗的效果。方法随机将2017年1月—2018年8月该院90例小儿哮喘急性发作患儿分为观察组(45例,应用常规治疗+硫酸沙丁胺醇+普米克令舒治疗)、对照组(45例,应用常规治疗+硫酸沙丁胺醇治疗)。对比两组患儿的疗效、肺功能指标、症状缓解时间。结果①在总有效率方面,观察组(95.56%)高于对照组(77.78%)(χ^2=6.154,P<0.05);②观察组患者治疗后FEV1[(2.38±0.36)L]、FVC[(1.94±0.30)L]、PEF[(195.16±20.45)L/min]高于对照组[(2.02±0.26)L、(1.42±0.31)L、(179.13±19.23)L/min](t=5.438、8.086、3.831,P<0.05);③观察组患儿咳嗽、喘息、呼吸困难、哮鸣音症状缓解时间均短于对照组(P<0.05)。结论对小儿哮喘急性发作患儿实施普米克令舒+硫酸沙丁胺醇治疗十分可行,有助于缩短症状缓解时间及改善肺功能。
Objective To investigate the effect of Pulmicort Resin+Salbutamol Sulfate on children with acute asthma attacks.Methods From January 2017 to August 2018,90 children with acute asthma attack in our hospital were randomly divided into observation group(45 cases,with routine treatment+salbutamol sulfate+Pulmicort treatment)and control group(45 cases,with conventional treatment+salbutamol sulfate treatment).The efficacy,lung function index,and symptom relief time of the two groups were compared.Results 1.In terms of total effective rate,the observation group(95.56%)was higher than the control group(77.78%)(χ^2=6.154,P<0.05);2.After treatment,in the observation group,FEV1[(2.38±0.36)L],FVC[(1.94±0.30)L],and PEF[(195.16±20.45)L/min]were higher than those in the control group[(2.02±0.26)L,(1.42±0.31)L,(179.13±19.23)L/min](t=5.438,8.86,3.831,P<0.05);3.The cough,wheezing,dyspnea,and wheezing symptoms of the observation group were shorter than those of the control group(P<0.05).Conclusion Pulmicort Resin+Salbutamol Sulfate can be used to treat the children with acute asthma attack.It can shorten the time of symptom relief and improve lung function.
作者
李娜
LI Na(Dalian Children's Hospital,Dalian,Liaoning Province,116012 China)
出处
《系统医学》
2019年第12期113-115,共3页
Systems Medicine
作者简介
李娜(1983-),女,辽宁大连人,硕士,主治医师,研究方向:儿呼吸感染科。
